S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
S&P 500   4,570.13 (+0.56%)
DOW   35,775.11 (+0.27%)
QQQ   377.83 (+1.00%)
AAPL   148.96 (+0.18%)
MSFT   309.03 (-0.04%)
FB   326.14 (+0.47%)
GOOGL   2,754.00 (+0.10%)
TSLA   988.79 (+8.70%)
AMZN   3,325.56 (-0.30%)
NVDA   232.71 (+2.40%)
BABA   176.22 (-0.83%)
NIO   41.14 (+5.81%)
CGC   13.28 (-0.75%)
GE   105.85 (+1.73%)
AMD   123.00 (+2.65%)
MU   68.87 (+2.01%)
T   25.46 (-0.12%)
F   15.87 (-2.52%)
ACB   7.10 (+0.42%)
DIS   172.16 (+1.62%)
PFE   42.95 (-0.49%)
BA   212.28 (-0.32%)
AMC   37.10 (+1.37%)
OTCMKTS:GSTC

GlobeStar Therapeutics Short Interest Ratio and Short Volume

$0.02
0.00 (-2.48 %)
(As of 10/22/2021 03:57 PM ET)
Add
Compare
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.04
52-Week Range
$0.01
$0.09
Volume1.55 million shs
Average Volume5.04 million shs
Market Capitalization$11.06 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.35

GlobeStar Therapeutics (OTCMKTS:GSTC) Short Interest Data

Current Short Volume7,500 shares
Previous Short Volume500 shares
Change Vs. Previous Month+1,400.00%
Dollar Volume Sold Short$222.00
Short Interest Ratio / Days to Cover0.0
Last Record DateSeptember, 30 2021
Outstanding Shares561,496,000 shares
Percentage of Shares Shorted0.00%
Today's Trading Volume1,549,400 shares
Average Trading Volume5,036,909 shares
Today's Volume Vs. Average-69.24%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling GlobeStar Therapeutics ?

Sign up to receive the latest short interest report for GlobeStar Therapeutics and its competitors with MarketBeat's FREE newsletter.

GlobeStar Therapeutics (OTCMKTS:GSTC) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/20217,500 shares $222.00 +1,400.0%N/A0 $0.03
9/15/2021500 shares $15.45 No ChangeN/A0 $0.03
7/30/202149,500 shares $1,910.70 +5,400.0%N/A0 $0.04
7/15/2021900 shares $0.00 No ChangeN/A0 $0.00

GlobeStar Therapeutics (OTCMKTS:GSTC) Short Interest FAQ













GlobeStar Therapeutics (OTCMKTS:GSTC) Short Interest Frequently Asked Questions

What is GlobeStar Therapeutics' current short interest?

Short interest is the volume of GlobeStar Therapeutics shares that have been sold short but have not yet been closed out or covered. As of September 30th, investors have sold 7,500 shares of GSTC short. Learn More on GlobeStar Therapeutics' current short interest.

Is GlobeStar Therapeutics' short interest increasing or decreasing?

GlobeStar Therapeutics saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 7,500 shares, an increase of 1,400.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does GlobeStar Therapeutics' short interest compare to its competitors?

0.00% of GlobeStar Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to GlobeStar Therapeutics: Oncotelic Therapeutics, Inc. (0.00%), CURE Pharmaceutical Holding Corp. (0.00%), NeuroBo Pharmaceuticals, Inc. (1.10%), Addex Therapeutics Ltd (0.00%), Metacrine, Inc. (1.28%), Pulmatrix, Inc. (2.20%), Acerus Pharmaceuticals Co. (0.00%), Soligenix, Inc. (2.64%), Elite Pharmaceuticals, Inc. (0.00%), and Tenax Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short GlobeStar Therapeutics stock?

Short selling GSTC is an investing strategy that aims to generate trading profit from GlobeStar Therapeutics as its price is falling. GlobeStar Therapeutics' stock is trading down $0.00 today. To short GlobeStar Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that GlobeStar Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against GlobeStar Therapeutics?

A short squeeze for GlobeStar Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GSTC, which in turn drives the price of the stock up even further.

How often is GlobeStar Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GSTC, twice per month. The most recent reporting period available is September, 30 2021.



This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.